Outgoing CEO, Chris Bunka, to remain on as Chairman of the Board of Directors and Executive Strategic Advisor KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a… Read More
ROCKVILLE, MD & EDMONTON, AB – Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announced that the first participant has been dosed in a Phase 1a single ascending dose… Read More
SOUTH SAN FRANCISCO, CA – Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer, announced that the… Read More
Annual Awards Program Recognizes Innovation in Agricultural and Food Technologies around the Globe VANCOUVER, BC — Renaissance BioScience, a leader in yeast bioengineering, is pleased to announce that it has… Read More
Despite decades of advancement in treatment, cancer spreading to multiple parts of the body remains one of the biggest challenges facing patients and their health care teams. This is particularly… Read More
